2026-11-092026-11-09https://scholars.csmu.edu.tw/handle/123456789/38065Metastasis of cancer cells, a primary cause of cancer death and a multiple and intricate processes, may complicate the clinical management and lead to a poor prognosis for cancer patients and has tremendous physical or economical impact to patients or communities. Degradation of ECM by cancer cells via protease, such as serine proteinase, metalloproteinases (MMPs), cathepsins, and plasminogen activator (PA), may lead to the separation of intercellular matrix to promote the mobility of cancer cells and eventually lead to metastasis. MMPs have been known to be deeply involved in various physiological activities, such as tissue repair, fetus implantation, wound healing, angiogenesis and apoptosis, as well tissue fibrosis and cardiovascular diseases. In addition, highly expressed MMP-2 and -9 have been detected in various malignant tumors and closely related to metastasis and invasion of cancer cells. Meanwhile, the activity of MMPs is prone to the inhibition of endogenous tissue inhibitor of metalloproteinases (TIMPs), which are specific inhibitors of MMPs, and the imbalance between MMPs and TIMPS may contribute to degradation or deposition of ECM. It has been well established that Chinese herbal medicines have beneficial effects for various symptoms of cancers. So far, various Chinese herbal medicines have been confirmed to possess an activity against inflammation, allergy and cancers, while some of active ingredients have been isolated and identified. The anticancer mechanisms of these active ingredients are to effectively promote apoptosis, inhibit the proliferation, invasion and metastasis of cancer cells. However, there are still inadequate researches to establish the detailed mechanisms. With a few established techniques, including zymography, immunoblotting, and RT-PCR for MMPs, u-PA, and t-PA, our Lab is very capable of performing studies on genes relevant to ECM-degradation, such as MMPs, TIMPs, plasmin, t-PA, and u-PA to clarify their involvements in anticancer ability. Therefore, the following objectives will be done in this project, including (1) to analyze the impacts of 50 Chinese herbal medicines on the cell adhesion, motility, migration and invasion of various cancer cells, including cancers of lung and liver cancer (2) to investigate the impacts of 50 Chinese herbal medicines on the expression of genes relevant to ECM-degradation, such as MMPs, TIMPs, t-PA, u-PA, and PAIs of various cancer cells, including cancers of lung and liver cancer; and (3) to use the animal model to evaluate the impacts by the addition of Chinese herbal medicines and their applications. Key words: metastasis, tumor cell, Chinese herbal medicines癌瘤細胞的轉移(metastasis) 是癌症導致死亡以及使治療複雜度提昇的主要原因;癌瘤細胞之所以能轉移主要是透過癌瘤細胞分泌蛋白分解酵素如 serine proteinase,metalloproteinase (MMPs) ,cathepsins以及 plasminogen activator (PA) 分解ECM,最後導致intercellular matrix 分離,進而使癌瘤細胞motility,migration及invasion提昇。Martrix metalloproteinase (MMPs)為一群含鋅之蛋白分解酵素,它會參與ECM的合成與分解;於正常生理情況下,參與如胚胎的發育,胚胎的著床,血管生成和組織重建等;另外,許多證據顯示這些活化後MMPs可受內生性組織抑制劑 (tissue inhibitor of metalloproteinases;TIMPs)調節而改變其活性,也就是說MMPs 與TIMPs之間imbalance 為決定 ECM 分解或堆積的,甚至癌瘤細胞吸附,位移,侵入和轉移的主要因素。中藥對癌症所引起的諸多症狀的治療能有所助益,已是不爭的事實。目前已有多種中藥已被確認具有抗發炎,抗過敏及抗癌的活性,而其中有關活性的有效成份,部分已被單離並經分析鑑定。而中藥之抗癌有效成份之作用機轉,為有效地促使凋謝死亡及抑制癌瘤細胞增生,侵襲及轉移,但對其詳細機制及系統生物學方面的研究及建立尚很少。 直至目前,本實驗室已經建立了MMPs,u-PA,t-PA之 zymography技術,與上述這些蛋白質 immnoblotting 技術以及 RT-PCR 技術,以從事ECM 降解相關基因的探討,如 MMPs,TIMPs,t-PA,u-PA 在中藥抗癌作用中可能參與的角色。 因此本計畫擬進行(1)分析50種中藥對癌瘤細胞如肺癌及肝癌等細胞之cell adhesion,motility,migration 及invasion活性的影響;(2)探討50種中藥對癌瘤細胞如肺癌及肝癌等細胞之ECM分解相關基因表現量的影響,包括 MMPs,TIMPs,t-PA,u-PA,PAIs;(3)利用動物模式探討中藥對抑制癌瘤細胞生長及轉移的影響。 關鍵字: 轉移;中藥;癌瘤細胞;轉移癌瘤細胞中藥metastasisChinese herbal medicinetumor cell中藥抑制癌瘤細胞遷移和侵犯作用之系統分析研究Project